Antibody Production Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)

The Antibody Production Market is Segmented by Antibody Type, Process, End User, and Geography.

Antibody Production Market Snapshot

Antibody Production Market 1
Study Period: 2018 - 2026
Base Year: 2020
Fastest Growing Market: Europe
Largest Market: North America
CAGR: 13.22 %

Need a report that reflects how COVID-19 has impacted this market and its growth?

Market Overview

The major factors for the growth of the antibody production market include the rising adoption of targeted immunotherapy, the increase in the R&D expenditure of pharmaceutical and biotechnology companies, and the rising demand for therapeutic antibodies.

Antibodies are used in the treatment of various diseases, such as cancer, rheunmatoid arthritis, and other chronic diseases. The targeted therapy is attaining importance due to its specificity toward cancer cells, while sparing the toxicity to off-target cells. As there is a rising prevalence of cancer, targeted therapies are getting more attention. For instance, according to the estimates of the American Cancer Society, in 2018, there were 1,735,350 new cancer cases diagnosed and 609,640 deaths, due to cancer, in the United States. Some of the examples of monoclonal antibodies used in targeted therapies are bevacizumab, cetuximab, and ipilimumab.

The rising adoption of targeted therapies are expected to propel the overall growth of the antibody production market over the forecast period. Furthermore, there is an increase in R&D activities by most of the pharmaceutical and biotechnology companies, in order to develop advanced biologics. The success rates and blockbuster sales of biologics have also made large pharmaceutical companies shift their presence to biopharma. Over the past two decades, the chimerization and humanization of mAbs (monoclonal antibodies) have led to the approval of several drugs & therapies for the treatment of autoimmune diseases, cancer, and transplant rejection.

However, the costs of anitbody production and stringent government regulations are expected to impede the growth of the market.

Scope of the Report

As per the scope of the report, antibody production refers to the process of creating a specific antibody. In a broad sense, it consists of various methods, such as upstream, downstream, and filtration. The process involves the preparation of antigen samples, which are injected to the laboratory or farm animals to evoke high expression levels of antigen-specific antibodies in the serum, which are then recovered from the animal. The market is expected to witness a significant growth, owing to the increase in R&D expenditure of pharmaceutical and biotechnology companies. Antibody Production Market is segmented By Antibody Type, By Process, By End User and Geography.

Antibody Type
Monoclonal Antibodies
Polyclonal Antibodies
Other Antibody Types
Process
Upstream Processing
Bioreactors
Consumables
Downstream Processing
Chromatography Systems
Chromatography Resins
Filtration
End User
Pharmaceutical and Biotechnology Companies
Research Laboratories
Other End Users
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East & Africa
GCC
South Africa
Rest of Middle East & Africa
South America
Brazil
Argentina
Rest of South America

Report scope can be customized per your requirements. Click here.

Key Market Trends

THe Monoclonal Antibodies Segment under the Antibody Type Accounted for the Largest Share in the Global Market

Monoclonal antibodies have large applications in the field of diagnostics, therapeutics, and targeted drug delivery systems, not only for infectious diseases caused by bacteria, viruses, and protozoa, but also for cancer, metabolic, and hormonal disorders. This segment is expected to account for the largest market share during the forecast period, owing to the rising investment in monoclonal antibody research and an increase in antibody-based product launches. Furthermore, there is a growing collaboration between pharma companies to develop advanced monoclonal antibodies. For instance, recently, in September 2018, Integral Molecular and Merus NV announced that they have entered into a collaboration on multiple undisclosed targets, as Integral Molecular is one of the leaders in membrane protein antibody discovery. The partnership is expected to increase the R&D capabilities of Merus NV.

The polyclonal antibody segment is expected to be the fastest-growing market, owing to benefits, such as ease of production, low price, and diagnosis of diseases with high proficiency.

Antibody Production Market Trend Image.png

North America Accounted for the Largest Share in the Global Market

North America is found to hold a significant share in the antibody production market and is expected to show a similar trend over the forecast period, without substantial fluctuations. The presence of favorable healthcare infrastructure and the rising prevalence of various chronic diseases are the major factors driving the growth of the market. Furthermore, there is a rise in the approval of monoclonal antibodies for the treatment of cancer and various types of diseases, which is one of the major factors contributing to the high growth of the market in North America. For instance, in May 2018, Novartis announced that the US FDA approved Kymriah (tisagenlecleucel) suspension for the treatment of adult patients with relapsed or refractory large B-cell lymphoma.

Antibody Production Market - Growth Rate by Region

Competitive Landscape

The market studied is dominated by a few major players, and is expected to grow, owing to the rising collaboration and partnerships between pharmaceutical and biotechnology companies, in order to develop advanced monoclonal antibodies.

Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Deliverables

    2. 1.2 Study Assumptions

    3. 1.3 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Rising Adoption of Targeted Immunotherapy

      2. 4.2.2 Increase in the R&D Expenditure of Pharmaceutical and Biotechnology Companies

      3. 4.2.3 Rising Demand for Therapeutic Antibodies

    3. 4.3 Market Restraints

      1. 4.3.1 High Costs Involved in the Antibody Production

      2. 4.3.2 Stringent Government Regulations

    4. 4.4 Porter's Five Forces Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION

    1. 5.1 Antibody Type

      1. 5.1.1 Monoclonal Antibodies

      2. 5.1.2 Polyclonal Antibodies

      3. 5.1.3 Other Antibody Types

    2. 5.2 Process

      1. 5.2.1 Upstream Processing

        1. 5.2.1.1 Bioreactors

        2. 5.2.1.2 Consumables

      2. 5.2.2 Downstream Processing

        1. 5.2.2.1 Chromatography Systems

        2. 5.2.2.2 Chromatography Resins

      3. 5.2.3 Filtration

    3. 5.3 End User

      1. 5.3.1 Pharmaceutical and Biotechnology Companies

      2. 5.3.2 Research Laboratories

      3. 5.3.3 Other End Users

    4. 5.4 Geography

      1. 5.4.1 North America

        1. 5.4.1.1 United States

        2. 5.4.1.2 Canada

        3. 5.4.1.3 Mexico

      2. 5.4.2 Europe

        1. 5.4.2.1 Germany

        2. 5.4.2.2 United Kingdom

        3. 5.4.2.3 France

        4. 5.4.2.4 Italy

        5. 5.4.2.5 Spain

        6. 5.4.2.6 Rest of Europe

      3. 5.4.3 Asia-Pacific

        1. 5.4.3.1 China

        2. 5.4.3.2 Japan

        3. 5.4.3.3 India

        4. 5.4.3.4 Australia

        5. 5.4.3.5 South Korea

        6. 5.4.3.6 Rest of Asia-Pacific

      4. 5.4.4 Middle East & Africa

        1. 5.4.4.1 GCC

        2. 5.4.4.2 South Africa

        3. 5.4.4.3 Rest of Middle East & Africa

      5. 5.4.5 South America

        1. 5.4.5.1 Brazil

        2. 5.4.5.2 Argentina

        3. 5.4.5.3 Rest of South America

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 Applikon Biotechnology Inc.

      2. 6.1.2 Cellab GmbH

      3. 6.1.3 Danaher Corporation

      4. 6.1.4 Eppendorf AG

      5. 6.1.5 GE Healthcare

      6. 6.1.6 Genetix Biotech Asia Pvt Ltd

      7. 6.1.7 Merck KGaA

      8. 6.1.8 Sartorius AG

      9. 6.1.9 Solaris Biotech

      10. 6.1.10 Thermo Fisher Scientific Inc.

    2. *List Not Exhaustive
  7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The Antibody Production Market market is studied from 2018 - 2026.

The Antibody Production Market is growing at a CAGR of 13.22% over the next 5 years.

Europe is growing at the highest CAGR over 2021- 2026.

North America holds highest share in 2020.

Eppendorf AG, GE Healthcare, Sartorius AG, ThermoFisher Scientific, Danaher Corporation are the major companies operating in Antibody Production Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!